A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

Cynthia S. Palmer; Bess Miller; Michael T. Halpern; Lawrence J. Geiter

doi:10.1097/00124784-199805000-00002

A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

Cynthia S. Palmer, Bess Miller, Michael T. Halpern, Lawrence J. Geiter

Community, Environment and Policy

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

A hypothetical cohort of 25,000 TB patients and their contacts were followed for a 10-year period; rates of treatment default, infectiousness following partial treatment, relapse, hospitalization, and development of drug-resistant TB were included. The average cost per case cured was $16,846 with 15% of patients starting DOT, $17,323 with 100% starting DOT, and $20,106 with none starting DOT. The incremental cost per additional case cured was $24,064 when all patients, started treatment on DOT, indicating that outpatient DOT provides a cost-effective method of improving health outcomes for TB patients and their contacts while controlling direct costs.

Original language	English (US)
Pages (from-to)	1-13
Number of pages	13
Journal	Journal of Public Health Management and Practice
Volume	4
Issue number	3
DOIs	https://doi.org/10.1097/00124784-199805000-00002
State	Published - May 1998

Keywords

Cost effectiveness
Costs
Decision model
Health economics
Public health
Tuberculosis

ASJC Scopus subject areas

Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1097/00124784-199805000-00002

Cite this

@article{07d9479479cc4bbfbeab2054b013e42f,

title = "A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis",

abstract = "A hypothetical cohort of 25,000 TB patients and their contacts were followed for a 10-year period; rates of treatment default, infectiousness following partial treatment, relapse, hospitalization, and development of drug-resistant TB were included. The average cost per case cured was $16,846 with 15% of patients starting DOT, $17,323 with 100% starting DOT, and $20,106 with none starting DOT. The incremental cost per additional case cured was $24,064 when all patients, started treatment on DOT, indicating that outpatient DOT provides a cost-effective method of improving health outcomes for TB patients and their contacts while controlling direct costs.",

keywords = "Cost effectiveness, Costs, Decision model, Health economics, Public health, Tuberculosis",

author = "Palmer, {Cynthia S.} and Bess Miller and Halpern, {Michael T.} and Geiter, {Lawrence J.}",

year = "1998",

month = may,

doi = "10.1097/00124784-199805000-00002",

language = "English (US)",

volume = "4",

pages = "1--13",

journal = "Journal of Public Health Management and Practice",

issn = "1078-4659",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "3",

}

TY - JOUR

T1 - A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

AU - Palmer, Cynthia S.

AU - Miller, Bess

AU - Halpern, Michael T.

AU - Geiter, Lawrence J.

PY - 1998/5

Y1 - 1998/5

N2 - A hypothetical cohort of 25,000 TB patients and their contacts were followed for a 10-year period; rates of treatment default, infectiousness following partial treatment, relapse, hospitalization, and development of drug-resistant TB were included. The average cost per case cured was $16,846 with 15% of patients starting DOT, $17,323 with 100% starting DOT, and $20,106 with none starting DOT. The incremental cost per additional case cured was $24,064 when all patients, started treatment on DOT, indicating that outpatient DOT provides a cost-effective method of improving health outcomes for TB patients and their contacts while controlling direct costs.

AB - A hypothetical cohort of 25,000 TB patients and their contacts were followed for a 10-year period; rates of treatment default, infectiousness following partial treatment, relapse, hospitalization, and development of drug-resistant TB were included. The average cost per case cured was $16,846 with 15% of patients starting DOT, $17,323 with 100% starting DOT, and $20,106 with none starting DOT. The incremental cost per additional case cured was $24,064 when all patients, started treatment on DOT, indicating that outpatient DOT provides a cost-effective method of improving health outcomes for TB patients and their contacts while controlling direct costs.

KW - Cost effectiveness

KW - Costs

KW - Decision model

KW - Health economics

KW - Public health

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0032059689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032059689&partnerID=8YFLogxK

U2 - 10.1097/00124784-199805000-00002

DO - 10.1097/00124784-199805000-00002

M3 - Article

C2 - 10186738

AN - SCOPUS:0032059689

SN - 1078-4659

VL - 4

SP - 1

EP - 13

JO - Journal of Public Health Management and Practice

JF - Journal of Public Health Management and Practice

IS - 3

ER -

A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this